NCT01249521View on ClinicalTrials.gov

Dual Targeting of Vascular Endothelial Growth Factor-A Together With Angiopoietins in Chemotherapy-naïve Metastatic Colorectal Cancer

PHASE2UnknownINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2012

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG

AMG386 and bevacizumab

AMG386 10mg/kg qw iv Bevacizumab 7.5mg/kg q3w iv

Trial Locations (1)

3084

RECRUITING

Austin Health, Melbourne

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Austin Health

OTHER_GOV